Macrophage Migration Inhibitory Factor (MIF) in CNS Diseases: Functional Regulation and Potential Therapeutic Indication

Overview

Journal Fundam Res

Date 2024 Dec 30

PMID 39734533

Authors

Yu Zhang

Zhexiang Yu

Na Ye

Xuechu Zhen

Affiliations

Soon will be listed here.

Abstract

Macrophage migration inhibitory factor (MIF) is a multifunctional protein that possesses cytokine, enzyme, and endocrine activities and acts as a chaperone-like molecule. Owing to its immune-inflammatory regulatory properties, the role of MIF has long been an attractive target in research on various autoimmune and inflammatory disorders. MIF is also widely expressed in the central nervous system (CNS), and its potential roles in CNS disorders have become a focus to elucidate the physiological and pathological effects of MIF and to explore its potential significance in the treatment of CNS diseases. Previously, the majority of work on MIF functional regulation was focused on MIF tautomerase inhibitors. However, mounting information has indicated that the functions of MIF extend far beyond its tautomerase activity. Here, we review the recent advances in understanding the complex roles of MIF in the pathogenesis of CNS disorders as well as the discovery and design of small molecules targeted to tautomerase and nuclease of MIF.

Citing Articles

Mapping Inflammatory Markers in Cerebrospinal Fluid Following Aneurysmal Subarachnoid Hemorrhage: An Age- and Sex-Matched Analysis.

Seyfried K, Kremer B, Conzen-Dilger C, Veldeman M, Bertram U, Blume C Int J Mol Sci. 2025; 26(3).

PMID: 39941070 PMC: 11818219. DOI: 10.3390/ijms26031302.

References

Petralia M, Battaglia G, Bruno V, Pennisi M, Mangano K, Lombardo S . The Role of Macrophage Migration Inhibitory Factor in Alzheimer's Disease: Conventionally Pathogenetic or Unconventionally Protective?. Molecules. 2020; 25(2). PMC: 7024279. DOI: 10.3390/molecules25020291. View

Sun C, Li H, Leng L, Raizada M, Bucala R, Sumners C . Macrophage migration inhibitory factor: an intracellular inhibitor of angiotensin II-induced increases in neuronal activity. J Neurosci. 2004; 24(44):9944-52. PMC: 6730251. DOI: 10.1523/JNEUROSCI.2856-04.2004. View

Bloom J, Al-Abed Y . MIF: mood improving/inhibiting factor?. J Neuroinflammation. 2014; 11:11. PMC: 3901340. DOI: 10.1186/1742-2094-11-11. View

Inacio A, Ruscher K, Leng L, Bucala R, Deierborg T . Macrophage migration inhibitory factor promotes cell death and aggravates neurologic deficits after experimental stroke. J Cereb Blood Flow Metab. 2010; 31(4):1093-106. PMC: 3070968. DOI: 10.1038/jcbfm.2010.194. View

Angelopoulou E, Pyrgelis E, Piperi C . Emerging Potential of the Phosphodiesterase (PDE) Inhibitor Ibudilast for Neurodegenerative Diseases: An Update on Preclinical and Clinical Evidence. Molecules. 2022; 27(23). PMC: 9737612. DOI: 10.3390/molecules27238448. View

Edwards K, Bosch J, Engeland C, Cacioppo J, Marucha P . Elevated macrophage migration inhibitory factor (MIF) is associated with depressive symptoms, blunted cortisol reactivity to acute stress, and lowered morning cortisol. Brain Behav Immun. 2010; 24(7):1202-8. DOI: 10.1016/j.bbi.2010.03.011. View

Mitchell R, Liao H, Chesney J, Fingerle-Rowson G, Baugh J, David J . Macrophage migration inhibitory factor (MIF) sustains macrophage proinflammatory function by inhibiting p53: regulatory role in the innate immune response. Proc Natl Acad Sci U S A. 2002; 99(1):345-50. PMC: 117563. DOI: 10.1073/pnas.012511599. View

Borsini A, Di Benedetto M, Giacobbe J, Pariante C . Pro- and anti-inflammatory properties of interleukin (IL6) in vitro: relevance for major depression and for human hippocampal neurogenesis. Int J Neuropsychopharmacol. 2020; . PMC: 7745251. DOI: 10.1093/ijnp/pyaa055. View

El Turk F, Fauvet B, Ouertatani-Sakouhi H, Lugari A, Betzi S, Roche P . An integrative in silico methodology for the identification of modulators of macrophage migration inhibitory factor (MIF) tautomerase activity. Bioorg Med Chem. 2010; 18(14):5425-40. DOI: 10.1016/j.bmc.2010.05.010. View

10.

Liang C, Li J, Zhang Z, Zhang J, Liu S, Yang J . Suppression of MIF-induced neuronal apoptosis may underlie the therapeutic effects of effective components of Fufang Danshen in the treatment of Alzheimer's disease. Acta Pharmacol Sin. 2018; 39(9):1421-1438. PMC: 6289349. DOI: 10.1038/aps.2017.210. View

11.

Swoboda C, Deloch L, von Zimmermann C, Richter-Schmidinger T, Lenz B, Kornhuber J . Macrophage Migration Inhibitory Factor in Major Depressive Disorder: A Multilevel Pilot Study. Int J Mol Sci. 2022; 23(24). PMC: 9779321. DOI: 10.3390/ijms232415460. View

12.

Burnette E, Ray L, Irwin M, Grodin E . Ibudilast attenuates alcohol cue-elicited frontostriatal functional connectivity in alcohol use disorder. Alcohol Clin Exp Res. 2021; 45(10):2017-2028. PMC: 8602728. DOI: 10.1111/acer.14696. View

13.

Cox G, Kithcart A, Pitt D, Guan Z, Alexander J, Williams J . Macrophage migration inhibitory factor potentiates autoimmune-mediated neuroinflammation. J Immunol. 2013; 191(3):1043-54. DOI: 10.4049/jimmunol.1200485. View

14.

Zhou Y, Guo W, Zhu Z, Hu Y, Wang Y, Zhang X . Macrophage migration inhibitory factor facilitates production of CCL5 in astrocytes following rat spinal cord injury. J Neuroinflammation. 2018; 15(1):253. PMC: 6122456. DOI: 10.1186/s12974-018-1297-z. View

15.

Cui D, Peng Y, Zhang C, Li Z, Su Y, Qi Y . Macrophage migration inhibitory factor mediates metabolic dysfunction induced by atypical antipsychotic therapy. J Clin Invest. 2018; 128(11):4997-5007. PMC: 6205380. DOI: 10.1172/JCI93090. View

16.

Popp J, Bacher M, Kolsch H, Noelker C, Deuster O, Dodel R . Macrophage migration inhibitory factor in mild cognitive impairment and Alzheimer's disease. J Psychiatr Res. 2008; 43(8):749-53. DOI: 10.1016/j.jpsychires.2008.10.006. View

17.

Zhong X, Ao Q, Xing F . Serum Levels of HCY, MIF, and hs-CRP Correlate with Glycolipid Metabolism in Adults with Never-Medicated First-Episode Schizophrenia. Evid Based Complement Alternat Med. 2021; 2021:7394699. PMC: 8605916. DOI: 10.1155/2021/7394699. View

18.

Vandenbark A, Meza-Romero R, Benedek G, Offner H . A novel neurotherapeutic for multiple sclerosis, ischemic injury, methamphetamine addiction, and traumatic brain injury. J Neuroinflammation. 2019; 16(1):14. PMC: 6346590. DOI: 10.1186/s12974-018-1393-0. View

19.

Brosseron F, Maass A, Kleineidam L, Ravichandran K, Gonzalez P, McManus R . Soluble TAM receptors sAXL and sTyro3 predict structural and functional protection in Alzheimer's disease. Neuron. 2022; 110(6):1009-1022.e4. DOI: 10.1016/j.neuron.2021.12.016. View

20.

Li M, Briones M, Heinzerling K, Kalmin M, Shoptaw S . Ibudilast attenuates peripheral inflammatory effects of methamphetamine in patients with methamphetamine use disorder. Drug Alcohol Depend. 2019; 206:107776. PMC: 7012103. DOI: 10.1016/j.drugalcdep.2019.107776. View